| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.055 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |